D. Wilson

WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.

S. Barry, K. Samuel, S. Forbes, 2015, The Journal of clinical investigation.

Inhibition of JAK/STAT signaling stimulates adult satellite cell function

Nicolas A. Dumont, M. Rudnicki, F. Price, 2014, Nature Medicine.

Non-canonical Wnt signalling regulates scarring in biliary disease via the planar cell polarity receptors

O. Sansom, T. Kendall, L. Boulter, 2020, Nature Communications.

DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01

J. Pollard, M. Kagey, L. Boulter, 2022, Liver international : official journal of the International Association for the Study of the Liver.

In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma

Martin S. Taylor, S. Wigmore, P. Tennant, 2022, Cancer research.

In vivo modelling of patient genetic heterogeneity identifies concurrent Wnt and PI3K activity as a potent driver of invasive cholangiocarcinoma growth

Martin S. Taylor, S. Wigmore, P. Tennant, 2021, bioRxiv.

Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1

S. Forbes, J. Iredale, E. Freyer, 2019, Nature Communications.

Non-canonical Wnt signalling initiates scarring in biliary disease

T. Kendall, L. Boulter, C. Dean, 2018, bioRxiv.

WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.

S. Barry, K. Samuel, S. Forbes, 2015, The Journal of clinical investigation.